Position in JANX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$35,246,561
-$13,224,337 QoQ
Shares Held
2,535,724
-27.8% QoQ
Ownership
4.16%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JANX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FMR LLC holds $49,682,018,247 across 354 Biotechnology names. JANX ranks #108 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
14,579,166 | $4,823,808,652 | |
| 2 | ARGX |
Argenx SE
|
4,991,034 | $3,644,702,577 | |
| 3 | MRNA |
Moderna, Inc.
|
45,672,024 | $2,320,138,818 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
77,981,253 | $2,160,080,705 | |
| 5 | INSM |
INSMED Inc
|
13,160,167 | $2,151,950,504 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,556,637 | $1,843,957,869 | |
| 7 | RPRX |
Royalty Pharma plc
|
25,152,242 | $1,206,553,046 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,518,192 | $1,173,015,865 |
All Filings in JANX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $35,246,561 | 2,535,724 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $48,470,898 | 3,512,384 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $221,330,154 | 9,056,062 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $205,329,939 | 8,888,742 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $239,869,944 | 8,884,072 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $464,188,638 | 8,669,941 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $355,474,983 | 7,824,675 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $325,803,662 | 7,777,600 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $291,750,187 | 7,749,009 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $50,122,114 | 4,671,213 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $64,021,324 | 6,351,322 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $60,095,387 | 5,062,796 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $62,201,791 | 5,140,644 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $73,829,175 | 5,605,860 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $84,589,686 | 6,247,392 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $71,131,844 | 5,825,704 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $81,407,117 | 5,676,926 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $98,480,360 | 4,991,402 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $78,201,771 | 3,615,431 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $45,996,921 | 1,843,564 | Shares | Defined | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||